Background: Many of present chemotherapeutics are inadequate and also resistant against visceral leishmaniasis (VL), an immunosuppressive ailment caused by . Despite the interest in plant-based drug development, no antileishmanial drugs from plant source are currently available. had been reported in favor of being immune modulators along with other traditional uses. Novel anti-VL therapies can rely on host immune-modulation with associated leishmanicidal action.
Objective: Discovery of novel plant-based antileishmanial compound from having permissible side effects.
Methods: With this rationale, an n-BuOH fraction of the methanolic extract of were evaluated against acellular and intracellular . Immunostimulatory activity of them was confirmed by elevated TNF-α and extracellular NO production from treated MФs and was found nontoxic to the host cells. Identification and structure confirmation for isolated Spergulin-A was performed by ESI-MS,C, and H NMR.
Results: Spergulin-A was found ineffective against the acellular forms while, against the intracellular parasites at 30 μg/mL, the reduction was 92.6% after 72 hrs. Spergulin-A enhanced ROS and nitric oxide (NO) release and changes in Gp91-phox, i-NOS, and pro and anti-inflammatory cytokines elaborated its intracellular anti-leishmanial activity.
Conclusion: The results supported that can potentiate new lead molecules for the development of alternative drugs against VL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756365 | PMC |
| http://dx.doi.org/10.2147/IDR.S211721 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of novel inhibitors from as anti-leishmanial agents targeting DDX3-DEAD box RNA helicase of .
3 Biotech
January 2025
Cell and Molecular Biology Laboratory, Department of Zoology, Soban Singh Jeena University, Campus Almora, Almora, Uttarakhand India.
Unlabelled: Visceral leishmaniasis (VL), caused by , remains challenging to treat due to severe side effects and increasing drug resistance associated with current chemotherapies. Our study investigates the anti-leishmanial potential of from Uttarakhand, India, with extracts prepared from leaves and stems using ethanol and hexane. Advanced GC-MS analysis identified over 100 bioactive compounds, which were screened using molecular docking to assess their binding to LdHEL-67, a DDX3-DEAD box RNA helicase of donovani.
View Article and Find Full Text PDFDevelopment of novel dual-target drugs against visceral leishmaniasis and combinational study with miltefosine.
Free Radic Biol Med
November 2024
School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, Uttar Pradesh, India. Electronic address:
Article Synopsis
- Two dual-target inhibitors (ZINC000008876351 and ZINC000253403245) were discovered using advanced computational methods to inhibit critical enzymes FeSODA and TryR in Leishmania donovani, showing strong enzyme inhibition in low μM concentrations.
- Flow cytometry results indicated that these compounds significantly increased reactive oxygen species (ROS) levels in treated cells, suggesting they effectively disrupt the parasite's antioxidant defense.
- The inhibitors demonstrated dose-dependent anti-leishmanial activity against both stages of the parasite and showed a synergistic effect when combined with miltefosine, which is especially relevant due to rising resistance against miltefosine in some Leishmania strains.
Detection and counting of intracellular parasites in microscopy images.
Front Med Technol
August 2024
Centro de Investigaciones de la Informática (CII), Universidad Central "Marta Abreu" de Las Villas, Santa Clara, Cuba.
Problem: Leishmaniasis is a disease caused by protozoan parasites of the genus and has a high prevalence and impact on global health. Currently, the available drugs for its treatment have drawbacks, such as high toxicity, resistance of the parasite, and high cost. Therefore, the search for new, more effective, and safe drugs is a priority.
View Article and Find Full Text PDFAnti-Leishmania effect of icetexanes from Salvia procurrens.
Phytomedicine
August 2024
Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil. Electronic address:
Background And Purpose: Leishmaniasis is a globally prevalent vector-borne disease caused by parasites of the genus Leishmania. The available chemotherapeutic drugs present problems related to efficacy, emergence of parasite resistance, toxicity and high cost, justifying the search for new drugs. Several classes of compounds have demonstrated activity against Leishmania, including icetexane-type diterpenes, previously isolated from Salvia and other Lamiaceae genera.
View Article and Find Full Text PDFAnti- Properties of (Yellow Water Lily) Leaf Extracts and Purified 6,6' Dihydroxythiobinupharidine (DTBN).
Pathogens
May 2024
Shraga Segal Dept. of Microbiology Immunology and Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.
Cutaneous leishmaniasis (CL) is a zoonotic disease, manifested as chronic ulcers, potentially leaving unattractive scars. There is no preventive vaccination or optimal medication against leishmaniasis. Chemotherapy generally depends upon a small group of compounds, each with its own efficacy, toxicity, and rate of drug resistance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!